603676 logo

Tibet Weixinkang Medicine Co., Ltd. Stock Price

SHSE:603676 Community·CN¥4.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

603676 Share Price Performance

CN¥11.26
0.30 (2.74%)
CN¥11.26
0.30 (2.74%)
Price CN¥11.26

603676 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet second-rate dividend payer.

2 Risks
1 Reward

Tibet Weixinkang Medicine Co., Ltd. Key Details

CN¥1.2b

Revenue

CN¥482.8m

Cost of Revenue

CN¥685.5m

Gross Profit

CN¥463.4m

Other Expenses

CN¥222.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.51
58.67%
19.01%
0%
View Full Analysis

About 603676

Founded
2006
Employees
689
CEO
Yong Zhang
WebsiteView website
www.wxkpharma.com

Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China. The company offers parenteral nutrition vitamins; electrolyte supplements; intravenous iron, trace, electrolytes, and amino acids supplements; antibiotics; acetylcysteine solution for inhalation; medicine for liver diseases; and other special fields. It also offers injection multivitamins, potassium magnesium aspartate for injection, iron sucrose injection, potassium aspartate injection, etc. The company was formerly known as Weixinkang Medicine Youxian Gongsi and changed its name to Tibet Weixinkang Medicine Co., Ltd. in 2015. Tibet Weixinkang Medicine Co., Ltd. was founded in 2002 and is based in Lhasa, China.

Recent 603676 News & Updates

Recent updates

No updates